IGC Pharma, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
IGC Pharma, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2011 to Q3 2024.
  • IGC Pharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 7, 2024 was 77.4M shares, a 21.5% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 77.4M +13.7M +21.5% Nov 7, 2024 10-Q 2024-11-12
Q2 2024 75.6M +22.6M +42.5% Jun 18, 2024 10-K 2024-06-24
Q4 2023 63.7M +10.7M +20.1% Feb 12, 2024 10-Q 2024-02-14
Q3 2023 63.7M +10.7M +20.1% Nov 7, 2023 10-Q 2023-11-09
Q2 2023 53.1M +1.33M +2.58% Jul 6, 2023 10-K 2023-07-07
Q4 2022 53.1M +2.02M +3.96% Feb 1, 2023 10-Q 2023-02-14
Q3 2022 53.1M +2.02M +3.95% Oct 19, 2022 10-Q 2022-11-01
Q2 2022 51.7M +3.42M +7.07% Jun 6, 2022 10-K 2022-06-23
Q4 2021 51.1M +5.69M +12.5% Jan 31, 2022 10-Q 2022-02-10
Q3 2021 51.1M +9.75M +23.6% Oct 18, 2021 10-Q 2021-10-29
Q2 2021 48.3M +7.14M +17.3% Jun 7, 2021 10-K 2021-06-14
Q4 2020 45.4M +6.05M +15.4% Feb 9, 2021 10-Q 2021-02-16
Q3 2020 41.3M +1.73M +4.38% Nov 11, 2020 10-Q 2020-11-20
Q2 2020 41.2M +1.67M +4.24% Jun 24, 2020 10-K 2020-07-13
Q4 2019 39.3M -267K -0.67% Jan 23, 2020 10-Q 2020-02-10
Q3 2019 39.6M +3.22M +8.87% Oct 15, 2019 10-Q 2019-11-06
Q2 2019 39.5M +8.48M +27.3% Jun 11, 2019 10-K 2019-06-14
Q4 2018 39.6M +9.3M +30.7% Jan 31, 2019 10-Q 2019-02-12
Q3 2018 36.3M +8.28M +29.5% Oct 9, 2018 10-Q 2018-10-16
Q2 2018 31M +457K +1.49% Jun 15, 2018 10-K 2018-06-21
Q4 2017 30.3M +2.68M +9.69% Jan 31, 2018 10-Q 2018-02-20
Q3 2017 28.1M -314K -1.11% Nov 13, 2017 10-Q 2017-11-17
Q2 2017 30.6M +7.24M +31% Jun 25, 2017 10-K 2017-07-14
Q4 2016 27.6M +9.64M +53.7% Jan 30, 2017 10-Q 2017-02-21
Q3 2016 28.4M +12M +73.7% Nov 8, 2016 10-Q 2016-11-21
Q2 2016 23.3M +8.48M +57% Jun 25, 2016 10-K 2016-07-14
Q4 2015 18M +2.92M +19.4% Feb 9, 2016 10-Q 2016-02-16
Q3 2015 16.3M +2.54M +18.4% Nov 3, 2015 10-Q 2015-11-13
Q2 2015 14.9M +3.48M +30.6% Jun 25, 2015 10-K 2015-07-14
Q4 2014 15M +7.06M +88.5% Feb 1, 2015 10-Q 2015-02-12
Q3 2014 13.8M +6.31M +84.4% Nov 3, 2014 10-Q 2014-11-13
Q2 2014 11.4M +4.4M +63% Jun 25, 2014 10-K 2014-07-15
Q4 2013 7.98M -52.1M -86.7% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 7.48M -52.6M -87.5% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 6.98M -53.1M -88.4% Jun 25, 2013 10-K/A 2014-07-15
Q4 2012 60.1M Dec 15, 2012 10-Q 2013-02-13
Q3 2012 60.1M +39.1M +187% Oct 15, 2012 10-Q 2012-11-14
Q2 2012 60.1M +39.1M +187% Jun 25, 2012 10-K 2012-07-16
Q3 2011 21M Nov 14, 2011 10-Q 2011-11-18
Q2 2011 21M Aug 8, 2011 10-Q 2011-08-18
Q1 2011 52.5M Feb 15, 2011 10-Q 2012-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.